![Thomas Klaue](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Klaue
Directeur Général chez
INJEX Pharma AG
Profil
Thomas Klaue currently works at INJEX Pharma AG, as Chief Executive Officer from 2013 and Siqens GmbH, as Chief Executive Officer from 2022.
Dr. Klaue also formerly worked at MediGene AG, as Chief Financial Officer.
Postes actifs de Thomas Klaue
| Sociétés | Poste | Début |
|---|---|---|
INJEX Pharma AG
 INJEX Pharma AG Medical SpecialtiesHealth Technology Manufactures needle free injection equipment | Directeur Général | 30/06/2013 |
Siqens GmbH
 Siqens GmbH Electrical ProductsProducer Manufacturing Develops methanol fuel cells for serial production | Directeur Général | 01/07/2022 |
Anciens postes connus de Thomas Klaue
| Sociétés | Poste | Fin |
|---|---|---|
| MEDIGENE AG | Directeur Financier/CFO | 19/04/2010 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
13
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
MediGene AG
 MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
INJEX Pharma AG
INJEX Pharma AG Medical SpecialtiesHealth Technology Manufactures needle free injection equipment | Health Technology |
Siqens GmbH
Siqens GmbH Electrical ProductsProducer Manufacturing Develops methanol fuel cells for serial production | Producer Manufacturing |
